LabGenius

Founded: 2012 · London, United Kingdom · 51-200 employees · Private

About LabGenius

LabGenius is a drug discovery company pioneering the use of machine learning for the discovery of novel therapeutic antibodies. Its proprietary EVA™ platform integrates artificial intelligence, robotic automation, and synthetic biology to accelerate the identification and co-optimization of complex therapeutic antibodies. The company focuses on developing selectivity-enhanced antibodies for the treatment of solid tumors.

Company Details

Website: https://labgeniustx.com
Funding: Series B
Total Raised: £58M
LinkedIn: https://uk.linkedin.com/company/labgeniustx

Specializations

AI/ML
Drug Discovery
Biotechnology
Protein Engineering
Therapeutic Antibodies

Products & Solutions (1)

Product	Category	Sub-Category	Description
EVA Platform	research-development	Drug Discovery AI	Automated ML-driven antibody optimization

Notable Customers

Sanofi